|
Volumn 55, Issue 5, 2012, Pages 631-636
|
Erratum: Hepatitis B and C: Report of the FISPGHAN working group (Journal of Pediatric Gastroenterology and Nutrition (2012) 55 (631-635) DOI: 10.1097/MPG.0b013e318272b61e);Hepatitis B and C: Report of the FISPGHAN working group
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR;
BOCEPREVIR;
ENTECAVIR;
HEPATITIS B SURFACE ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B VACCINE;
HEPATITIS C VACCINE;
IMMUNOLOGICAL ADJUVANT;
INTERFERON;
LAMIVUDINE;
PEGINTERFERON;
PEGINTERFERON ALPHA;
PROTEINASE INHIBITOR;
RIBAVIRIN;
TELAPREVIR;
TELBIVUDINE;
ADAPTIVE IMMUNITY;
ANTIBODY PRODUCTION;
ANTIVIRAL ACTIVITY;
ANTIVIRAL RESISTANCE;
ARTICLE;
BREAST FEEDING;
CHILD HEALTH CARE;
DEPRESSION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
EARLY DIAGNOSIS;
EDUCATION PROGRAM;
FLU LIKE SYNDROME;
GROUPS BY AGE;
HEALTH EDUCATION;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS C VIRUS;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE SYSTEM;
IMMUNIZATION;
INFECTION RISK;
INNATE IMMUNITY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
MATERNAL WELFARE;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
MIXED INFECTION;
MULTICENTER STUDY (TOPIC);
NEWBORN INFECTION;
PANCYTOPENIA;
PATIENT REFERRAL;
PHYSICIAN ATTITUDE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SEROCONVERSION;
SEROPREVALENCE;
TREATMENT OUTCOME;
VERTICAL TRANSMISSION;
VIRUS TRANSMISSION;
|
EID: 84869084387
PISSN: 02772116
EISSN: 15364801
Source Type: Journal
DOI: 10.1097/MPG.0000000000002014 Document Type: Erratum |
Times cited : (4)
|
References (13)
|